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Gastrointestinal (GI) disturbances are among the most common health challenges faced by the 
suckling neonate, and dietary interventions aimed to modulate inflammation and microbial 
colonization may provide a prophylactic option to enhance GI development.  The objective of this 
experiment was to investigate the effects of supplemental ARA or prebiotics (alone or combined) 
on intestinal inflammation and the microbiome in an acute dextran sodium sulfate (DSS) colitis 
model.   Day-old pigs were randomized among 4 diets (0.5% arachidonic acid (ARA; control); 
4g/L galactooligosaccharide + 4 g/L polydextrose (PRE); 2.5% ARA, and PRE+ARA; n=24/diet, 
and were fed 3 times per d for 21d.  On d17-21 pigs (12 per diet) were treated with 0.625 g DSS/kg 
BW to induce colitis.  Pigs were euthanized on d22 and samples were collected for digesta pH, 
histology, and systemic cytokines.   Supplements did not affect growth.  There was a main effect 
of PRE on decreasing ileal, cecal, proximal and distal colon digesta pH compared with diets 
lacking PRE (7.4 vs. 7.3 ± 0.03; 6.2 vs 5.8 ±0.06; 6.3 vs 5.7 ± 0.04; 6.4 vs. 6.0 ± 0.04, respectively; 
P<0.05).  PRE and DSS both increased laxation scores with highest diarrhea being found in pigs 
fed PRE and challenged with DSS (P<0.05).  In addition, pathology assessments (means ± SEM)  
showed main effects of diet and DSS on epithelial damage, lamina propria inflammation, crypt 
abscess, crypt dropout, and overall colitis score (P < 0.05).  In conclusion supplementation of 
formula with prebiotics significantly modulates laxation, histopathology, and digesta pH.   
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Introduction 
Gastrointestinal (GI) maladies are one of the top causes of neonatal morbidity and mortality 
in human infants (1) as well as mammalian livestock species (2). An impaired GI microbiota and 
inflammation in infancy can alter subsequent immune and physiological response to challenges 
later in life (3). Neonatal nutrition is a critical component in the establishment of normal GI 
function and this function is vitally important in reducing neonatal morbidity and mortality (4). 
Gastrointestinal diseases are a source of substantial human medical cost in the United States, with 
direct and indirect spending estimated at $142 billion per year (5). It is also a major issue for the 
swine industry, with diarrheal scours being among one of the top causes of death in nursery piglets 
(6).  
The piglet has gained much popularity as a pediatric research model (7,8). The 
gastrointestinal tract of the pig has proven to be more similar to that of the human than other 
domestic and research animal species (9,10). Additionally, the developmental age of the pig is 
more similar to human infants than rodent models (11). Postnatal intestinal development in piglets 
is more similar to human infants than rodent models, and immunological responses of the mucosal 
immune system in piglets is quite similar to the human infant (12). 
Suckling piglet research serves to provide a foundational understanding of nutritional 
regulation of the developing gastrointestinal tract of neonatal piglets as well as human infant. This 
knowledge in neonatal nutrition can be applied in the swine industry to reduce the effects of 
intestinal maladies pre- and post-weaning that can negatively impact production systems by 
increasing the farrow to finish interval through decreased feed efficiency and increasing mortality 
in the herd. As of 2012, the USDA reported that 3.6% of nursery pigs die and of this group, 9% of 
the piglet death is caused by scours. Scours can lead to failure to thrive which itself has an even 
greater detrimental effect on survival by eliminating 22.1 % of nursery piglets (6). This is the 
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second greatest cause of death in the nursery phase and why nutritional interventions during early 
phase of development are critical. Additionally, without the ability to feed antibiotics, there is an 
increasing need to understand and provide nutritional intervention. Neonatal nutrition, in the form 
of mother’s milk or milk replacer, provides the sole source of nutrition to the developing neonate 
in a critical period of growth and development (3). In addition to providing the sustenance for 
growth and development, neonatal nutrition also provides the foundation of immunological 
development and health. Proper formulation of formulas when a mother’s milk cannot be 
consumed is critical to the developing neonate during the time of consumption when consequences 
of inadequate nutrition are most severe. Bioactive nutrient supplementation in formulas has been 
steadily improving, with long chained polyunsaturated fatty acids (LCPUFA) arachidonic acid 
(ARA) and docosahexaneoic acid (DHA) now being added in amounts to formula that are found 
in mother’s milk. More recent research has had the focus on prebiotic supplementation into infant 
formulas, specifically galactooligosaccharides (GOS) and polydextrose (PDX). There is a great 
need to improve function and efficacy of formula nutrients and bioactive components in preventing 
inflammation and promoting gastrointestinal health. 
The single layer of intestinal epithelial cells serves as a barrier and gatekeeper protecting 
the underlying mucosal immune system from overstimulation by the abundant gut lumen antigens. 
The intestinal enterocytes and mucosal immune cells participate in developing immunologic 
tolerance, and are responsive to environmental cues to maintain intestinal mucosal homeostasis 
(13). Barrier function is enhanced by the microbial ecosystem which will produce key signaling 
molecules known as microbial-associated molecular patterns (MAMP; such as peptidoglycan, 
LTA, LPS, etc.) that will bind to pattern recognition receptors (PRR; such as TLRs, NODs, 
PGlyRP, etc.) of mucosal cells and allow for an immune response when stimulated by antigens 
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(7,8). Innate and adaptive immune response in the developing intestine can be modulated by 
inflammatory transcription factors, PPARy and NFkB, which alter the balance of anti- and 
proinflammatory cytokines (8,14,15). Furthermore, elements of both barrier function and innate 
immune response in mucosal epithelium are responsive to dietary nutrients, and dietary associated 
changes in the intestinal microbiome (16-21).  
Prebiotics can help to mediate controlled inflammation and gut barrier function. Prebiotics 
are selectively fermented non-digestible ingredients that allow specific changes in both the luminal 
microbial population and their activity to promote intestinal health by being fermented to short 
chain fatty acids (SCFA) which can help to enhance barrier function (22). Polydextrose (PDX) 
supplementation in formula-fed piglets can increase Lactobacilli and decrease luminal pH which 
results from lactic acid concentrations in the colon (23,24). Galactooligosaccharides (GOS) 
supplementation has been shown to increase counts of bifidobacteria and can clinically help to 
improve conditions in the case of ulcerative colitis (27, 28). Supplementation of prebiotics to 
formula fed pigs can also reduce recovery time and improve infection-associated symptoms 
following Salmonella typhimurium infections by reducing diarrhea and increasing intestinal 
epithelium TER (24).  
Milk oligosaccharides (MOs) are known most commonly as being prebiotics which are 
selectively fermented non-digestible ingredient that allow specific changes in both the luminal 
microbial population and their activity to promote intestinal health through SCFA production (25). 
MOs are a complex mixture of indigestible carbohydrates with a high degree of structural diversity 
and represent one of the largest groups of bioactive components in mother’s milk and can influence 
neonatal mucosal and systemic innate immunity (26). Oligosaccharides are the 3rd most abundant 
component of milk, with approximately 200 molecular species of oligosaccharides being identified 
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in human milk and are synthesized from D-glucose, D-galactose, D-N-acetylglucosamine, L-
fucose, and D-N-acetylneuraminic acid (sialic acid) monomers (23). Porcine milk oligosaccharides 
(PMO) are beneficial prebiotics to neonatal piglets. Like humans within a lactation, composition 
and concentration of PMO will change slightly (26). Although research in the past has pointed 
towards bovine MOs being the closest in composition to human milk, porcine MOs will have a 
similar profile of HMOs just at lower concentrations than found in humans (29). Intestinal 
physiopathology of both the human and porcine species has been shown to be very similar and 
with MO composition having similar profiles, this suggests similar effects on gastrointestinal 
development of early nutrition in the neonate, whether it be the piglet or the human infant (30). 
The microbiome of the gut is thought to be heavily influenced by environment due to the low 
heritability of the microbiome (31). Prebiotics are antiadhesive antimicrobials that serve as soluble 
decoy receptors, preventing pathogen attachment to the mucosal surface and lowering the risk for 
viral, bacterial and protozoan parasite infections.  In addition, oligosaccharides may modulate 
epithelial and immune cell responses, reduce excessive mucosal leukocyte infiltration and 
activation, lower the risk for necrotizing enterocolitis and provide the infant with sialic acid as a 
potentially essential nutrient for brain development and cognition (30). Diet influences gut 
colonization (31), and introducing milk as the first source of oral feeding is important for the 
establishment of health-promoting bacteria and such as bifidobacteria and lactobacilli  (32). When 
prebiotics are added to formulas, research has shown it can change gut metabolic activity, lower 
pH of stool, and significantly increase bifidobacteria count (33). Preterm infants often suffer from 
maladies due to a delayed acquisition of the “normal” digestive microflora stemming from 
restricted enteral feeding and frequent use of antibiotics (35).  Prebiotics have been shown to 
reduce amounts of pathogens found in the gut (34). In addition, Prebiotics have also been shown 
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to prevent or lessen the effects of gastrointestinal maladies ranging from mucosal injury to full-
thickness necrosis and perforation in preterm infants (33).  Long-chain polyunsaturated fatty acids 
(LCPUFA) can also help to mediate inflammatory balance and gut barrier function. LCPUFA 
contribute to perinatal growth and development. LCPUFA can foster gut health by having direct 
effects on inflammatory signaling through modulation of transcription factors, and production of 
eicosanoids which are critical to intestinal epithelial cell proliferation (15,36-38).  Modification of 
dietary LCPUFAs intake greatly impacts membrane structure through incorporation into cellular 
membranes phospholipids in many tissues, including brain, retina, and the intestine. (39-41). After 
ischemic injury, polyunsaturated fatty acid ARA can stimulate rapid recovery of gut barrier 
function and restore baseline levels of permeability (42-44) and can reduce histological lesions 
(36). There has also been evidence to show that piglets fed formula containing LCPUFA 
significantly influenced overall bacterial composition and the size of the Bacteroides community 
(45).  
Previous research has shown that LCPUFA and dietary prebiotics independently can 
improve neonatal response to inflammation (36,41). The goal of this study is to assess the 
synergistic effects of dietary prebiotics and LCPUFA on the neonate’s ability to resolve intestinal 
inflammation following dextran sodium sulfate (DSS) induced colitis. 
Methods 
Pigs and study design.  Full-term crossbred piglets were vaginally delivered at the daughter 
nucleus herd in Rocky Mount, NC (Hanor Farms, Inc.) and allowed to suckle colostrum for 24 h, 
after which they were transferred to the Developmental Nutrition Lab. Pigs were housed 
individually in an environmentally controlled room (32oC) programmed to a light/dark cycle of 
16/8 h.  The pigs were trained to suckle from a nipple plates for the first 24 h using control 
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diets.  The pigs were fed at ~60% ad libitum with fresh diet offered 3 times/d for 21 d to achieve 
growth rates similar to those of sow-fed pigs.  Body weights and milk refusals were measured 
daily along with qualitative diarrhea scores.  The experiment was conducted in 3 replicates.  All 
replicates included 8 pigs/dietary treatments and 4 pigs/diet/±DSS (n = 96 piglets total).  All 
animal procedures were approved by the University Institutional Animal Care and Use 
Committee.     
Diets.  Pigs were blocked within treatment by weight and litter of origin and randomly allotted to 
1 of 4 dietary treatments.  The four dietary treatments differ in prebiotic and fatty acid 
composition:1) formula containing no prebiotic and baseline LCPUFA (CONT); 2) formula 
enriched with 4g/L GOS + 4g/L PDX (PRE); 3) formula enriched with 2.5% ARA, or 4) formula 
enriched with both PRE+ARA. The composition of the basal liquid diet was as follows: milk by-
products (Milk Specialties Co., Dundee, IL), 93 g/L; fat supplied according to treatments, 45 g/L; 
vitamin minerals, 12 g/L; (Milk Specialties Co., Dundee, IL) and water, 850 mL/L. The dry matter 
content of the basal liquid diet was 15% and the calculated chemical analysis was (DM basis) 
crude protein, 31.1%; lactose, 36%; ether extract, 25%; and total energy, 4.6 Mcal/kg (696 kcal/L); 
basal diet composition is reported in Table 1.  A basal diet was patterned after term human infant 
formula, adjusted to meet the nutrient requirements of neonatal pigs.  Concentrations of prebiotic 
and LCPUFA were selected based upon previous dose-response studies conducted in our 
laboratory (23, 41). LCPUFA concentrations in the CONT diet match current industry standards 
while the enriched diet will contain 5X ARA.  At the time of reconstitution in water the basal diet 
was supplemented with oil blends and/or oligosaccharides.  Reconstituted formulas were 
homogenized and refrigerated before feeding.   
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Dextran Sodium Sulfate (DSS) Induction of Colitis.  To induce colitis, 4 piglets per dietary 
treatment group were selected at random to receive 0.625 g DSS /kg BW /d for five days beginning 
on d17 of the trial.  Pigs not receiving DSS treatment received an equal volume of sterile 
saline.  The DSS dose was determined by a previous dose response study conducted in our lab and 
was calculated daily based on daily BW.  Pigs remained on dietary treatments during the five day 
DSS challenge. On d22 following dosage with DSS pigs were euthanized by being anesthetized 
with isoflurane and then exsanguinate. The intestine was removed from 1 m proximal to the 
ileocecal junction to the anus. Digesta were collected from the ileum, cecum, proximal and distal 
colon.  The pH was determined on digesta from each intestinal segment, and samples were 
quantitatively distributed into cryotubes and frozen at -80oC for short-chain fatty acid analysis and 
microbial enumeration (these two analysis are still on-going).   
Sampling.   
Growth Performance and clinical assessments.  Daily clinical evaluations included measurement 
of BW, feed intake, observations of stool consistency, presence of blood in stool and overall 
animal well-being.  Feces were visually assessed and assigned a consistency score on a daily basis 
by the same person throughout the study. A laxation score of 0, 1, 2, 3 was recorded to indicate 
firm, soft but formed, runny, or severe watery diarrhea, respectively.  
Histopathological Measurements.  Colon tissue were fixed in 10% buffer formalin for 24 h and 
stored in 70% ethanol until tissue were ready to be sectioned.  Four colon tissue cross sections 
from each animal were embedded in paraffin blocks and stained with hematoxylin and eosin 
(H&E).  Colonic inflammation was scored by board certified pathologist (North Carolina State 
University, College of Veterinary Medicine, Raleigh, NC)  blinded to treatments.  Six different 
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measures were used to assess severity of colitis adapted from Kim et al. (2010).  Additionally, an 
overall colitis score was given to each sample. 
Mucosal and Blood Cytokine Profiles. Concentrations of systemic cytokine, TNFα were analyzed 
by ELISA (Quantikine ELISA kits according to manufacturer's instructions (Thermo Fisher 
Scientific/R&D Systems, Inc.)    
Statistical Analysis. Data were analyzed by two-way ANOVA as appropriate for a 2X2 factorial 
design (with repeated measures for BW, FI, and diarrhea scores) using SAS (SAS Institute, Cary, 
NC). When a significant interaction effect was detected, means were separated using a least-
significant-difference test.   
Results 
Growth performance and laxation scores 
There were no differences (P > 0.05) in initial and final body weights without DSS and 
with or without DSS, respectively (Table 2).  There was a highly significant diet by DSS 
interaction on diarrheal scores (P < 0.0001).   The interaction is due to increased stool laxation 
seen in prebiotic fed piglets regardless of LCPUFA addition (Table 3).  On d16, d17, and d18 
there was no significant effect of dietary treatment on diarrhea score. On d19, d20, d21, and d22 
diarrhea scores in CONT + DSS treatments were significantly higher (P < 0.03) than the CONT 
group.  Additionally, on d19 treatment group PRE + DSS had a significantly higher (P=0.03) 
diarrheal score. On d20 CONT + DSS continued to have a significantly higher diarrheal score 
when compared to just CONT (P=0.003) On d20 ARA + DSS began to have a significantly higher 
diarrheal score (P=0.003) when compared to ARA treatment with this trend continuing on for d21 
(P=0.002) and d22 (P=0.004). (Table 3).  
Pathology 
 
10 
 
The severity of colonic inflammation and the effect of supplementation of prebiotics, 
LCPUFA or both on DSS-induced colitis was evaluated by H & E staining of colon sections 
(Figures 1 and 2).  Assessments included the following measures epithelial damage, LP 
inflammation, crypt abscess, crypt dropout, goblet depletion, hyperplasia, and an overall colitis 
score.  Colon sections from DSS treated animals showed a distorted crypt architecture and 
infiltration of inflammatory cells into the mucosa and submucosa (P < 0.01).  There was an overall 
effect of DSS on colon architecture compared to no DSS treated pigs (P < 0.01).  Dietary treatments 
of prebiotics, arachidonic acid and the combination reduced showed trends in reduction of 
epithelial damage, crypt abscess, crypt dropout, and overall colitis score (P < 0.1).  Additionally, 
there were trends for additive effects on the prebiotic plus arachidonic acid combination on crypt 
architecture in DSS treated animals.    
Intestinal pH   
Ileal, cecal, proximal colon and distal colon digesta pH was significantly decreased by 
prebiotics in the diet (P < 0.01; Table 4).  There was also a significant main effect of DSS on 
digesta pH from the proximal and distal colon (P < 0.01).   There was no main effect of dietary 
ARA on digesta pH or an overall interaction of DSS x PRE x ARA (P > 0.05).  These data are in 
agreement with previous work showing addition of prebiotics changes the ileal, cecal and colonic 
pH by increasing organic acid production in the gut.   
Cytokine analysis  
 An ELISA was ran to determine TNF-α concentrations in the blood serum of 3 piglets per 
treatment with a total of 12 samples ran. Samples were taken on d1 of the DSS challenge (d17 of 
the trial) and also from d6 of DSS challenge (d22 of the trial) from each of the dietary treatment 
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groups. There were no significant changes in TNF-α concentrations from d1 to d6 in these animals 
(data not shown).  
Discussion 
Nutritional regulation of neonatal gut health is of primary importance for optimization of 
growth in neonates.  It is well documented that nutrition impacts gut development from digestion 
and absorption, development of homeostatic microbiota and developing a healthy mucosal 
immune system (3).  Previous work from our lab has shown supplementation of neonatal milk with 
LCPUFA (ARA or eicosapentanoic acid) will enrich phospholipid membranes of cells throughout 
the body, as well as, protect against intestinal injury and enhance repair following ischemic injury 
(36, 41).  Additionally, polydextrose and galactooligosaccharide decreased intestinal pH as well 
as alter microbial populations to enhance lactic acid producing bacteria (23).  Much research has 
been done to demonstrate the independent role of bioactive nutrients in altering intestinal health, 
but these reductive research methods do not represent the complexity of nutrients involved in 
modulation of intestinal health by mother’s milk. Therefore, this study investigated the 
independent effects on LCPUFA and prebiotic in a colitis challenge model, as well as, synergistic 
effects of the two nutrients.      
To understand the mechanisms in which gut health is modulated by dietary treatment 
growth performance, colon histological pathology, intestinal pH, and systemic TNF-were 
examined. Regardless of treatment, weight gain was not compromised when final body weight was 
analyzed with or without colitis.  Diarrheal scores were altered by dietary treatment with prebiotics 
which is supported by previous research (23).  However, the increased laxation prior to the 
intestinal challenge may have masked the impact of the DSS challenge on diarrhea in the prebiotic 
piglets. Increase in laxation scores was seen with all prebiotic treatment groups with or without 
the addition of ARA before colitis was induced and with worsening effects as the trial went on. 
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This data suggests that feeding prebiotics at these high amounts could have potential effects of 
increasing laxation scores of neonatal animals. By day four of the colitis challenge there was 
increased diarrhea in all dietary treatment groups treated with DSS.  
The diarrhea data is supported in the colonic histopathology work where there was an 
overall increase in colonic damage with DSS treatment, but there were trends for reduced injury 
of colonic architecture with PRE, ARA or the combination.  Epithelial damage and colonic 
abscesses and crypt dropout showed a trend for improvement following dietary treatment with 
these bioactive nutrients.  Others have shown that prebiotics impact intestinal health (14,23,25) 
but showing improved gut health with a 5-fold increase in ARA was a first time this has been 
shown.  Additional work is needed to understand the mechanisms of by which these bioactive 
nutrients may protect against intestinal injury, but it is safe to say there are most likely multiple 
layers to the effects seen.  The lowering the in intestinal pH is most likely correlated with changes 
in microbial populations in the gut.  Herfel et al. (23) showed that increasing concentration of PDX 
in neonatal pig diets decreased pH while increasing lactic acid and lactic acid producing bacteria.  
They also showed there were changes in bifidobacterium in the piglet gut, which have been 
associated with positive gut health in human infants (26).  These early population changes are 
important to establishing a ‘homeostatic’ microbiome and protecting against the development of a 
dysbiotic microbiome that could lead to lifelong immune challenges that are correlated with 
autoimmune diseases, such as diabetes, asthma, irritable bowel syndromes, and others (26).  
However, further work is needed to optimized dose of prebiotics associated with gut health since 
animals on the PRE treatments experienced diarrhea prior to intestinal challenge. 
Systemic TNF-α analysis proved to be nonsignificant with the small number of samples 
we have run, but local cytokine analysis and further systemic cytokine analysis must be done 
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before conclusions can be drawn. Overall, DSS had an effect of increasing damage of colon 
architecture and dietary treatments with a combination of prebiotic and ARA have the potential to 
protect the architecture in the colon. In addition, prebiotics proved to drop the intestinal pH to 
provide an environment for more beneficial bacteria but at the levels fed have a potential negative 
effect of increasing diarrhea. In conclusion, dietary prebiotics were seen to modulate colon 
pathohistology and the intestinal microbiome through lowering pH and increasing laxation scores 
during intestinal injury.  
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Table 1 Composition of basal (control) formula fed to newborn pigs for 21 d 
Basal Diet1 
Ingredient % 
Na caseinate 11.25 
Delactosed whey 18.11 
Dicalcium phosphate 1.88 
Calcium chloride 0.33 
Mineral premix2 0.50 
Vitamin premix3 0.12 
Artificial flavor 0.03 
Potassium sorbate 0.45 
D,L Methionine 0.49 
Whey 28.59 
Whey protein concentrate 18.15 
Edible lard 19.39 
Sodium hexametaphosphate 0.18 
Antioxidant 0.01 
Flow agent 0.14 
Emulsifier 0.22 
Lecithin 0.19 
TOTAL 100.00 
 
1Manufactured by Milk Specialties, Dundee, IL. 
2Mineral premix contained: 1 g/100 g Ca, 0.55 g/100 g P, 0.28 g/100 g Na, 0.04 g/100 g Cl, 2.02 
g/100 g K, 0.1 g/100 g Mg, 20,000 mg/g Fe, 200 mg/100 g Co, 1850 mg/g Cu, 400 mg/g I, 5000 
mg/g Mn, 60 mg/g Se, 23,500 mg/g Zn. 
3Vitamin premix contained: 9.9 g/kg retinol, 0.17 g/kg cholecalciferol, 55 g/kg α- tocopherol, 
117,000 mg/g ascorbic acid, 29,983 mg/g D-pantothenic acid, 33,069 mg/g niacin, 8378 mg/g 
riboflavin, 5115 mg/g menadione, 66 mg/g biotin, 44000 mg/g vitamin 
B-12, 2038 mg/g thiamin, 3996 mg/g vitamin B-6, 2756 mg/g folic acid. 
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Table 2.  Growth performance of neonatal pigs fed formulas containing LCPUFA and/or prebiotics for 21 d1 
 
No DSS  Plus DSS  
  
 CONT ARA PRE PRE + ARA CONT ARA PRE PRE + ARA SE P-value 
IBW (g)  1643.43 1655.09 1680.33 1616.79 1526.92 1503.32 1627.83 1546.56 58.0 0.28 
FBW (g)  5438.30 5437.83 5447.00 5271.05 5270.75 5160.40 5448.50 5448.50 101.6 0.35 
1Values ae means and pooled SEMs, n=12.  IBW, initial body weight; FBW, final body weight; CONT, control diet; ARA, 2.5% 
arachidonic acid in the diet; PRE, 4g/L polydextrose + 4g/L galactooligosaccharide; PRE + ARA, 2.5% arachidonic acid + 4g/L 
polydextrose + 4g/L galactooligosaccharide. 
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Table 3.  Diarrhea scores in piglets fed prebiotics, arachidonic acid, or both with or without a DSS colitis challenge 
 
No DSS  Plus DSS  
 
P-value  
 
CONT ARA PRE   PRE + ARA  CONT ARA PRE  PRE + ARA SE  DSS*PRE*ARA  DSS PRE  ARA  
d16 0.12c 0.17c 1.61b 1.93a 0.17c 0.08c 1.44b 2.06a 0.1 < 0.0001 0.88 < 0.0001 0.25 
d17 0.2d 0.08d 1.62b 1.94a 0.42c 0.08d 1.67b 1.84a 0.1 < 0.0001 0.65 < 0.0001 0.95 
d18 0.37c 0.33c 1.52b 1.98a 0.42c 0.42c 1.69b 1.92a 0.1 < 0.0001 0.59 < 0.0001 0.41 
d19 0.11e 0.08e 1.39b 1.92a 0.50c 0.25d 1.76a 1.90a 0.1 < 0.0001 0.15 < 0.0001 0.68 
d20 0.37d 0.41d 1.50b 1.99a 1.08c 1.08c 1.77a 2.00a 0.2 < 0.0001 0.009 < 0.0001 0.31 
d21 0.46c 0.83c 1.92a 1.89a 1.33b 1.58b 1.99a 1.91a 0.2 < 0.0001 0.004 < 0.0001 
0.52 
 
d22 0.46c 0.92b 1.93a 1.82a 1.25b 1.75a 1.99a 1.98a 0.2 < 0.0001 0.002 < 0.0001 0.23 
1Values ae means and pooled SEMs, n=12.  CONT, control diet; ARA, 2.5% arachidonic acid in the diet; PRE, 4g/L polydextrose + 
4g/L galactooligosaccharide; PRE + ARA, 2.5% arachidonic acid + 4g/L polydextrose + 4g/L galactooligosaccharide. 
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Figure 1.  Quantitative histological grading of neonatal pig colitis main effect of DSS.   
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Figure 2.  Quantitative histological grading of neonatal pig colitis dietary effects.   
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Table 4.  Digesta pH in piglets fed prebiotics, arachidonic acid, or both with or without a DSS colitis challenge 
 
No DSS  Plus DSS   p-value  
 
CONT ARA PRE PRE + ARA CONT ARA PRE PRE + ARA SE  DSS*PRE*ARA  DSS PRE  ARA  
Ileum 7.36ab 7.36ab 7.29b 7.31b 7.48a 7.4ab 7.32b 7.32b 0.04 0.66 0.12 0.01 0.62 
Cecum 6.22a 6.24a 5.74b 5.81b 6.27a 6.12b 5.99b 5.83b 0.08 0.96 0.40 < 0.0001 0.35 
Proximal Colon 6.38a 6.34a 5.72c 5.78c 6.21ab 6.09b 5.75c 5.71c 0.06 0.47 0.01 < 0.0001 0.44 
Distal Colon 6.50a 6.61a 6.10b 6.15b 6.22b 6.21b 5.88c 5.92bc 0.06 0.90 < 0.0001 < 0.0001 0.22 
1Values ae means and pooled SEMs, n=12.  CONT, control diet; ARA, 2.5% arachidonic acid in the diet; PRE, 4g/L polydextrose + 
4g/L galactooligosaccharide; PRE + ARA, 2.5% arachidonic acid + 4g/L polydextrose + 4g/L galactooligosaccharide. 
 
